Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

Plus Therapeutics (PSTV) R&D In Process (2017)

Plus Therapeutics (PSTV) has disclosed R&D In Process for 1 consecutive years, with $1.7 million as the latest value for Q1 2017.

  • On a quarterly basis, R&D In Process changed N/A to $1.7 million in Q1 2017 year-over-year; TTM through Dec 2017 was $1.7 million, a N/A change, with the full-year FY2021 number at $250000.0, down 67.99% from a year prior.
  • R&D In Process was $1.7 million for Q1 2017 at Plus Therapeutics.
  • In the past five years, R&D In Process ranged from a high of $1.7 million in Q1 2017 to a low of $1.7 million in Q1 2017.